Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Chenhai Liu

Aurora-A Inhibition Eliminates Myeloid Cell-Mediated Immunosuppression and Enhances the Efficacy of Anti-Pd-L1 Therapy in Breast Cancer

Cancer Research

Oncology

2019

English

The BET Inhibitor I-Bet762 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine

Scientific Reports

Multidisciplinary

2018

English

Related publications

Inhibition of COX-2 and EGFR by Melafolone Improves Anti-Pd-1 Therapy Through Vascular Normalization and PD-L1 Downregulation in Lung Cancer

Journal of Pharmacology and Experimental Therapeutics

Molecular Medicine

Pharmacology

2018

English

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

International Journal of Clinical Oncology

English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research

Cancer Research

Immunology

2014

English

Aspirin‐targeted PD‐L1 in Lung Cancer Growth Inhibition

English

The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

Journal for ImmunoTherapy of Cancer

English

Vitamin D Enhances the Efficacy of Photodynamic Therapy in a Murine Model of Breast Cancer

English

Pan-Tam Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-Pd-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

Cancer Research

Oncology

2019

English

PD-L1 Mediated the Differentiation of Tumor-Infiltrating CD19+B Lymphocytes and T Cells in Invasive Breast Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Chenhai Liu

Aurora-A Inhibition Eliminates Myeloid Cell-Mediated Immunosuppression and Enhances the Efficacy of Anti-Pd-L1 Therapy in Breast Cancer

The BET Inhibitor I-Bet762 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine

Related publications

Inhibition of COX-2 and EGFR by Melafolone Improves Anti-Pd-1 Therapy Through Vascular Normalization and PD-L1 Downregulation in Lung Cancer

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

PD-L1 Expression in Triple-Negative Breast Cancer

Aspirin‐targeted PD‐L1 in Lung Cancer Growth Inhibition

The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

Vitamin D Enhances the Efficacy of Photodynamic Therapy in a Murine Model of Breast Cancer

Pan-Tam Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-Pd-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

PD-L1 Mediated the Differentiation of Tumor-Infiltrating CD19+B Lymphocytes and T Cells in Invasive Breast Cancer